%0 Generic
%A Alerany, C.
%A Fernandez, R.
%A Landete, L.
%A Rodriguez, A.
%A Sandoval, S.
%A Valdivia, M.
%A Gil, A.
%T DETERMINING THE VALUE OF OCREVUS (R) (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
%D 2018
%@ 1098-3015
%U https://hdl.handle.net/10668/27568
%~